Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yu.O. Senko"'
Publikováno v:
Infusion & Chemotherapy, Iss 4, Pp 52-58 (2022)
BACKGROUND. Often in practice there are combinations of several diseases, or tuberculosis of the respiratory organs develops against the background of various comorbidities, including HIV. OBJECTIVE. To demonstrate best clinical practices for sele
Externí odkaz:
https://doaj.org/article/dabe6b2bac5e459084050f289d12ed08
Autor:
Yu.I. Feshchenko, N.A. Lytvynenko, M.V. Pohrebna, Yu.O. Senko, A.S. Lafeta, R.L. Lyubevych, Yu.О. Gamazin, Ya.S. Terleeva
Publikováno v:
Tuberculosis, Lung Diseases, HIV Infection. :5-10
Objective — to study the programmatic results of the efficacy and tolerability of the standard combination BPaL regimen for patients with multidrug-resistant tuberculosis failures and pre-XDR-TB. Materials and methods. Treatment of patients with
Autor:
V. V. Davydenko, S.P. Korotchenko, Yu.O. Senko, T.V. Senko, Nataliia Lytvynenko, L.M. Protsyk
Publikováno v:
Tuberculosis, Lung Diseases, HIV Infection. :67-75
Tuberculosis is a severe infectious disease that negatively affects not only the physical condition of patients, but also the psychological condition of patients. The first thing — the shock of the first diagnosis of tuberculosis for the patient. T
Autor:
L.M. Protsik, M. V. Pohrebna, Nataliia Lytvynenko, N.V. Grankina, Yu. I. Feshchenko, Yu.O. Senko
Publikováno v:
Tuberculosis, Lung Diseases, HIV Infection; № 3 (2020); 48-56
Туберкулез, легочные болезни, ВИЧ-инфекция; № 3 (2020); 48-56
Туберкульоз, легеневі хвороби, ВІЛ-інфекція; № 3 (2020); 48-56
Туберкулез, легочные болезни, ВИЧ-инфекция; № 3 (2020); 48-56
Туберкульоз, легеневі хвороби, ВІЛ-інфекція; № 3 (2020); 48-56
Objective — to study the profile of the MTB resistance and the results of treatment in patients with pulmonary tuberculosis with different profile of the MTB resistance and a history of previous treatment.Materials and methods. A retrospective coho
Autor:
Yu.O. Senko
Publikováno v:
Infusion & Chemotherapy. :257-258
Background. Yu-Port (“Yuria-Pharm”) is an implanted system for long-term infusions. This system allows multiple access to vessels for parenteral administration of drugs, fluids and nutrient solutions. Objective. To describe the safety and efficac
Autor:
Yu. I. Feshchenko, H. O. Varytska, L. V. Shcherbakova, Nataliia Lytvynenko, M. V. Pohrebna, O. P. Chobotar, Yu.O. Senko, N. Hrankina, V. V. Davydenko
Publikováno v:
Інфекційні хвороби.
The A im of work. Study the effectiveness of treatment among patients with multidrug resistant and extensively drug resistant tuberculosis using standard approaches for conventional antimycobacterial therapy and to present the first results of the ef